VJHemOnc Podcast
autor: VJHemOnc
iwMPN 2026 highlights: combination strategies in frontline…
O tomto podcastu
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts - from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases.
Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.
If you enjoy the podcast, please leave us a rating and review!
For more news visit www.vjhemonc.com
Epizody
Nejnovějších 20 z 200 epizod
- iwMPN 2026 highlights: combination strategies in frontline myelofibrosis and novel agents in the second-line setting · 31 min · Epizoda 359This podcast episode features two expert-led roundtable discussions from the recent 4th International Workshop on Myelodysplastic Syndromes and Myeloproliferative Neoplasms…
- Future perspectives in frontline MCL treatment and management: a European and US view · 17 min · Epizoda 358This VJHemOnc podcast episode explores future directions in frontline mantle cell lymphoma (MCL) treatment, focusing on the evolving role of chemotherapy, BTK inhibitors, and…
- Novel targets, combinations, and treatments in AML: highlights from iwAL 2026 · 21 min · Epizoda 357This episode of the VJHemOnc podcast features an exclusive expert-led roundtable discussion summarizing two sessions from the 8th International Workshop on Acute Leukemias (iwAL…
- IMS 2026 highlights: advances in multiple myeloma treatment and the path towards cure · 25 min · Epizoda 356In this episode of the VJHemOnc podcast, experts discuss key advances in multiple myeloma presented at the 23rd Annual Meeting and Exposition of the International Myeloma Society…
- Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management · 22 min · Epizoda 355This VJHemOnc podcast explores how BTK inhibitor therapy can be personalized for patients with chronic lymphocytic leukemia (CLL), considering disease biology, patient…
- Using BTK inhibitors in lymphoma: practical considerations for community physicians · 23 min · Epizoda 354This episode of the VJHemOnc podcast, featuring Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, focuses on the practical use of BTK inhibitors (BTKis) in…
- AAV gene therapy in hemophilia: progress, challenges and what comes next · 24 min · Epizoda 353This VJHemOnc podcast explores the evolving role of gene therapy in hemophilia, focusing on the challenges of AAV-based approaches and the development of next-generation…
- Clinical considerations in MCL management: frailty assessment, the multidisciplinary team & managing the use of BTKis · 18 min · Epizoda 352This VJHemOnc podcast explores the evolving management of mantle cell lymphoma (MCL), from assessing patient fitness to sequencing therapy after BTK inhibitor progression. Tycel…
- Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape · 24 min · Epizoda 351This VJHemOnc podcast explores the evolving treatment landscape in multiple myeloma, focusing on treatment selection and sequencing across the disease course. Fredrik Schjesvold…
- The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy · 24 min · Epizoda 350There has been a significant shift in the treatment of acute lymphoblastic leukemia (ALL), driven by the emergence of novel immunotherapies. In this episode, leading experts…
- Precision medicine in MDS: tailoring treatment through molecular profiling · 20 min · Epizoda 349This VJHemOnc podcast explores how precision medicine is reshaping the management of myelodysplastic syndromes (MDS). Alex Bataller, MD, PhD, The University of Texas MD Anderson…
- The current and future role of BTK inhibitors across non-Hodgkin lymphoma subtypes · 24 min · Epizoda 348This episode of the VJHemOnc podcast explores the current and future role of BTK inhibition across several non-Hodgkin lymphoma (NHL) subtypes. First, Charalampia Kyriakou, MD…
- The diagnosis and management of hematologic malignancies during pregnancy · 18 min · Epizoda 347In this episode of the VJHemOnc podcast, Daan Dierickx, MD, PhD, KU Leuven and University Hospitals Leuven, Leuven, Belgium, shares insight into the diagnosis and management of…
- Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse · 19 min · Epizoda 346This VJHemOnc podcast explores the latest advances in Hodgkin lymphoma, from evolving frontline treatment strategies to emerging approaches in relapsed and refractory disease…
- Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies · 20 min · Epizoda 345This podcast explores sequencing strategies and treatment considerations for BTK inhibitors in chronic lymphocytic leukemia (CLL). Jennifer Brown, MD, PhD, Dana-Farber Cancer…
- Precision medicine in AML: from targeted therapy to transplantation · 20 min · Epizoda 344This podcast explores the evolving role of precision medicine in acute myeloid leukemia (AML), highlighting advances in molecular profiling, targeted therapies, measurable…
- MPNs in focus: disease progression, risk assessment, and emerging treatments · 21 min · Epizoda 343This VJHemOnc podcast explores how advances in disease biology, risk stratification, and therapeutic development are reshaping the management of myeloproliferative neoplasms…
- The evolving role of cellular therapies and T-cell engagers in lymphoma · 19 min · Epizoda 342This VJHemOnc podcast explores emerging cellular therapies and T-cell engagers in non-Hodgkin lymphoma (NHL). Krish Patel, MD, Sarah Cannon Research Institute, Nashville, TN, is…
- Multiple myeloma in 2026: MRD, BCMA therapies, CAR-T, and the path to cure · 20 min · Epizoda 341This VJHemOnc podcast explores how evolving treatment strategies, immunotherapies, and MRD-driven approaches are reshaping the management of multiple myeloma and precursor…
- Dual-targeting CAR T-cell therapies in LBCL: efficacy, safety, and bridging therapy · 25 min · Epizoda 340This VJHemOnc podcast features a roundtable discussion from the 8th International Workshop on CAR-T and Bispecifics (iwCAR-T) 2026 on the evolving role of dual-targeting CAR…








